Selected category: Sanofi

The vaccine development process has transformed dramatically in recent years, driven by the urgent need for effective immunization against emerging contagious diseases. Traditional pipelines for the creation of novel vaccines relied on more than 10 years of research, preclinical investigations and clinical trials, but advanced laboratory technologies have led the way to rapid vaccine development, production and upscaling. Automation has enabled vaccine research to go beyond the bounds of what was previously possible in terms of reliability and throughput, leading to faster progress and new ways of designing experiments. The Vaccines Global Bioprocess Development Platform at Sanofi has recently automated its miniaturized chromatography workflows to speed up downstream processing, achieving even greater productivity and efficiency for the company’s workflows.